newsfilter
← Latest News
PR Newswire·

SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics

Milestone payment highlights ongoing clinical progress of Oral KORSUVA™ DALLAS, Oct. 10 2022 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH), a life sciences focused specialty finance company catering to